Cardiovascular risks in prediabetes: Preliminary data on "vasculopathy triad"

North American Journal of Medical Sciences

Volumn 6, Issue 7, 2014, Pages 328-332

  Nwose, Ezekiel Uba ^a,b   Richards, Ross S ^a   Bwititi, Phillip T ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

^b Department of Chemical Sciences   (Nigeria)

Author keywords

Atherothrombosis; Blood viscosity; Homocysteine; Laboratory evaluations; Subclinical vascular pathology

Indexed keywords

BIOLOGICAL MARKER; D DIMER; HOMOCYSTEINE;

ADULT; ARTICLE; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOSTASISVENOUS STASIS; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; OXIDATIVE STRESS; PREVALENCE; QUESTIONNAIRE; THROMBOSIS; VASCULAR DISEASE;

EID: 84904582364     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.136913     Document Type: Article

References (28)

1. Feldman EL. Oxidative stress and diabetic neuropathy: A new understanding of an old problem. J Clin Invest 2003;111:431-3.
2. Stitt AW. Advanced glycation: An important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001;85:746-53.
3. Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011;9:120-38.
4. Higgins C. Recurrence of venous thromboembolism. Biomed Sci 2006;50:865-7.
5. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complication. Br J Biomed Sci 2007;64:35-43.
6. Makin A, Silverman SH, Lip GY. Peripheral vascular disease and Virchow's triad for thrombogenesis. QJM 2002;95:199-210.
7. Lowe GD. Virchow's triad revisited: Abnormal flow. Pathophysiol Haemost Thromb 2003;33:455-7.
8. Malone PC, Agutter PS. Is 'Virchow's triad' useful? Br J Haematol 2009;145:839.
9. Bagot CN, Arya R. Virchow's triad: A question of attribution. Br J Haematol 2008;143:180-90.
10. Lincoff AM. Important triad in cardiovascular medicine: Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade. Circulation 2003;107:1556-9.
11. Nwose EU, Richards RS, Jelinek HF, Kerr PG. D-dimer identifies stages in the progression of diabetes mellitus from family history of diabetes to cardiovascular complications. Pathology 2007;39:252-7.
12. Richards RS, Nwose EU. Blood viscosity at different stages of diabetes pathogenesis. Br J Biomed Sci 2010;67:67-70.
13. Nwose EU, Cann NG, Butkowski E. Whole blood viscosity assessment issues III: Association with international normalized ratio and thrombocytopenia. N Am J Med Sci 2010;2:301-5.
14. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109:IV6-19.
15. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study. Br J Haematol 1997;96:168-73.
16. Nwose EU, Richards RS, Kerr PG, Tinley R, Jelinek HF. Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications. Br J Biomed Sci 2008;65:136-41.
17. Andrassy M, Bierhaus A, Hong M, Sis J, Schiekofer S, Humper PM, et al. Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-kappaB is inversely correlated with the hemoglobin level. Clin Nephrol 2002;58:179-89.
18. Dickson BC. Virchow's triad. Br J Haematol 2009;145:433.
19. Brown lee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005;54:1615-25.
20. Dincer Y, Akcay T, Alademir Z, Ilkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002;51:1360-2.
21. Dumaswala UJ, Zhuo L, Mahajan S, Nair PN, Shertzer HG, Dibello P, et al. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBC. Am J Physiol Cell Physiol 2001;280:C867-73.
22. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: Molecular and cellular mechanisms. Hypertension 2003;42:1075-81.
23. Lip G Y, Blann AD. Does hypertension confer a prothrombotic state? Virchow's triad revisited. Circulation 2000;101:218-20.
24. Lowe GD. Measurement of thrombosis and its prevention. Br J Clin Pharmacol 2002;54:96-100.
25. Nwose EU, Richards RS, McDonald S, Jelinek HF, Kerr PG, Tinley P. Assessment of diabetic macrovascular complications: A prediabetes model. Br J Biomed Sci 2010;67:59-66.
26. Nwose EU. Cardiovascular risk assessment and support techniques: Whole blood viscosity assessment issues I: Extrapolation chart and reference values. N Am J Med Sci 2010;2:165-9.
27. Tamariz LJ, Young JH, Pankow JS, Yeh HC, Schmidt MI, Astor B, et al. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: The atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 2008;168:1153-60.
28. Nwose EU, Cann NG. Whole blood viscosity issues VI: Association with blood salicylate level and gastrointestinal bleeding. N Am J Med Sci 2010;2:457-60